Cyclin F disruption compromises placental development and affects normal cell cycle execution

Mol Cell Biol. 2004 Mar;24(6):2487-98. doi: 10.1128/MCB.24.6.2487-2498.2004.

Abstract

Human cyclin F was originally isolated as a cDNA capable of suppressing the temperature sensitivity of a Saccharomyces cerevisiae cdc4-1 mutant. Its tightly regulated expression and high conservation in the evolutionary progression from amphibians to mammals suggest that it coordinates the timing of a critical cell cycle event. The fact that it contains an F box and can form an SCF (Skp1-Cul1/Cdc53-F-box) complex in vivo further suggests that it may also function in proteolysis. To investigate the role of cyclin F in vivo, we generated mice deficient for cyclin F and conditionally deficient mice as well as mouse embryonic fibroblasts (MEFs) conditionally deficient for cyclin F. Heterozygous animals are normal and fertile, but CycF(-/-) animals, with a myriad of developmental anomalies due in large part to failures in yolk sac and chorioallantoic placentation, die around embryonic day 10.5. Tissue-specific deletion of cyclin F revealed that it was not required for the development and function of a number of different embryonic and adult tissues. In contrast, MEFs lacking cyclin F, while viable, do exhibit cell cycle defects, including reduced population-doubling time and a delay in cell cycle reentry from quiescence, indicating that cyclin F plays a role in cell cycle regulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Cell Cycle / genetics
  • Cell Cycle / physiology*
  • Cell Survival
  • Cells, Cultured
  • Cyclins / deficiency*
  • Cyclins / genetics
  • Cyclins / physiology
  • DNA, Complementary / genetics
  • Embryonic and Fetal Development / genetics
  • Embryonic and Fetal Development / physiology
  • Female
  • Fetal Death / genetics
  • Gene Expression Regulation, Developmental
  • Heterozygote
  • Humans
  • Mice
  • Mice, Knockout
  • Phenotype
  • Placenta / abnormalities*
  • Placentation
  • Pregnancy
  • Restriction Mapping
  • Tissue Distribution

Substances

  • CCNF protein, human
  • Ccnf protein, mouse
  • Cyclins
  • DNA, Complementary